**Abstract**

**Objective:** Neuroinflammation has been recognized to play a role in progression of Alzheimer's disease(AD). Tumor necrosis factor(TNF)- α is one of the main proinflammatory cytokines that plays a central role in initiating and regulating the cytokine cascade during an inflammatory response. Interleukin(IL)-6 is a multifunctional cytokine that plays an important role in host defense, with major regulatory effects upon the inflammatory response. We measured serum levels of TNF-α and IL-6 in patients with AD, as compared to mild cognitive impairment(MCI) subjects and cognitively preserved older adults and analyzed its correlation with cognitive performance in these subjects.

**Methods:** The study included 92 subjects with AD(n=35), MCI(n=29) and normally cognitive function(n=28). The subjects' overall cognitive functions and disease severity were measured using Korean version of the Mini-Mental State Examination(MMSE-K), the Clinical Dementia Rating (CDR), and the Global Deterioration Scale(GDS). The blood IL-6 and TNF- levels were measured for subjects in all groups. The blood samples were stored in Vacutainer tubes containing citrate, were cooled with ice, and were immediately centrifuged at 3,000 rpm for 10 minutes. ANOVA was performed to analyze the statistical information of the serum IL-6 and TNF- α levels among all groups. The correlation between serum levels and several scores of cognitive function assessment was analyzed statistically.

**Results:** Among three groups, IL-6 levels in the AD group are significantly higher than MCI group and healthy controls(p=0.045). There is no difference of serum levels of TNF-α among all groups(p=0.082). MMSE-K score was negatively was positively correlated with TNF-α(p=0.025) and IL-6(0.006). GDS score was positively correlated with TNF-α(p=0.019) and IL-6(0.007). TNF-α and IL-6 were positively correlated with each other(p\<0.001).

**Conclusions:** The serum levels of IL-6 may be a candidate for identifying AD and its progression. AD. Our results suggested proinflammatory cytokine production seems, in part, to be implicated in neurological deleterious effects observed in the development and progression in AD.
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